Hough Ear Institute, Oklahoma City, OK 73112, USA.
Hough Ear Institute, Oklahoma City, OK 73112, USA; Otologic Pharmaceutics Inc., Oklahoma City, OK 73104, USA.
Mol Ther. 2018 May 2;26(5):1313-1326. doi: 10.1016/j.ymthe.2018.03.004. Epub 2018 Mar 10.
Deafness is commonly caused by the irreversible loss of mammalian cochlear hair cells (HCs) due to noise trauma, toxins, or infections. We previously demonstrated that small interfering RNAs (siRNAs) directed against the Notch pathway gene, hairy and enhancer of split 1 (Hes1), encapsulated within biocompatible poly(lactic-co-glycolic acid) nanoparticles (PLGA NPs) could regenerate HCs within ototoxin-ablated murine organotypic cultures. In the present study, we delivered this sustained-release formulation of Hes1 siRNA (siHes1) into the cochleae of noise-injured adult guinea pigs. Auditory functional recovery was measured by serial auditory brainstem responses over a nine-week follow-up period, and HC regeneration was evaluated by immunohistological evaluations and scanning electron microscopy. Significant HC restoration and hearing recovery were observed across a broad tonotopic range in ears treated with siHes1 NPs, beginning at three weeks and extending out to nine weeks post-treatment. Moreover, both ectopic and immature HCs were uniquely observed in noise-injured cochleae treated with siHes1 NPs, consistent with de novo HC production. Our results indicate that durable cochlear HCs were regenerated and promoted significant hearing recovery in adult guinea pigs through reversible modulation of Hes1 expression. Therefore, PLGA-NP-mediated delivery of siHes1 to the cochlea represents a promising pharmacologic approach to regenerate functional and sustainable mammalian HCs in vivo.
耳聋通常是由于噪声创伤、毒素或感染导致哺乳动物耳蜗毛细胞(HCs)的不可逆损失引起的。我们之前的研究表明,针对 Notch 通路基因 hairy 和 enhancer of split 1(Hes1)的小干扰 RNA(siRNA),封装在生物相容性的聚乳酸-共-羟基乙酸(PLGA)纳米颗粒(NPs)中,可以在耳毒素消融的鼠类器官培养物中再生 HCs。在本研究中,我们将这种 Hes1 siRNA(siHes1)的缓释制剂递送到噪声损伤的成年豚鼠耳蜗中。通过在九周的随访期间进行连续的听觉脑干反应来测量听觉功能的恢复,通过免疫组织化学评估和扫描电子显微镜来评估 HCs 的再生。在接受 siHes1 NPs 治疗的耳朵中,跨越广泛的音调范围观察到显著的 HCs 恢复和听力恢复,从治疗后 3 周开始,并持续到 9 周。此外,在接受 siHes1 NPs 治疗的噪声损伤耳蜗中,还观察到独特的异位和未成熟 HCs,与新生 HCs 的产生一致。我们的结果表明,通过可逆调节 Hes1 的表达,在成年豚鼠中,持久的耳蜗 HCs 得到了再生,并促进了显著的听力恢复。因此,PLGA-NP 介导的 siHes1 递送到耳蜗代表了一种有前途的药理学方法,可以在体内再生功能性和可持续的哺乳动物 HCs。